Floatz logo

Apixaban

Embolic Stroke of Undetermined Source

University Hospital TuebingenSmall moleculePhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Embolic Stroke of Undetermined Source cohort.

Asset / SponsorPhaseRating
Acetylsalicylic Acid
University Hospital Tuebingen
Phase 3BB
Empagliflozin
University of East Anglia
Phase 2/3B

Same molecule, other indications

Apixaban is also rated in:

venous thromboembolismDormant
BBB
Indicative ·
79 / 100
View asset →
venous thromboembolismDormant
BBB
Indicative ·
79 / 100
View asset →
atrial fibrillationDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →